Annual Revenue ($)

Amphastar Pharmaceuticals revenue was $322.36 m in FY, 2019

Quarterly Revenue ($)

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019
Revenue$210.46 m$251.52 m$255.17 m$240.18 m$294.67 m$322.36 m
Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$49 m$59.71 m$56.89 m$53.85 m$63.87 m$59.37 m$68.03 m$64.22 m$56.67 m$65.19 m$57.92 m$58.39 m$71.04 m$75.54 m$79.79 m$79.05 m$80.14 m$84.69 m$85.81 m$83.43 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Amphastar Pharmaceuticals revenue breakdown by business segment: 94.1% from Finished pharmaceutical products and 5.9% from Active Pharmaceutical Ingredients

FY, 2016FY, 2015
Finished pharmaceutical products$240.22 m$224.94 m
Active Pharmaceutical Ingredients$14.94 m$26.58 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu